MBX Biosciences Q3 EPS $(0.63) Beats $(0.70) Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
MBX Biosciences (NASDAQ:MBX) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.70) by 9.87 percent. This is a 77.34 percent increase over losses of $(2.78) per share from the
MBX Biosciences (NASDAQ:MBX) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.70) by 9.87 percent. This is a 77.34 percent increase over losses of $(2.78) per share from the same period last year.